Search

Displaying results 5831 - 5840 of 8469 in total
  1. Drug

    Inbakicept

    go.drugbank.com/drugs/DB16479
    Investigational

    [L50592] This combination product was approved by the FDA on April 22, 2024, for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without

  2. Drug

    Tarlatamab

    go.drugbank.com/drugs/DB17256
    ApprovedInvestigational

    [L50743] Tarlatamab-dlle was approved by the FDA in May 2024 for use in patients who have failed previous round of platinum-based chemotherapy,[L50743,L50748] becoming the first DLL3-targeting bispecific

  3. Drug

    Orlistat

    go.drugbank.com/drugs/DB01083
    ApprovedInvestigational

    It was approved by the FDA for use in combination with a reduced-calorie diet in 1999.

  4. Drug

    Nitric Oxide

    go.drugbank.com/drugs/DB00435
    ApprovedInvestigational

    This gas is an important signaling molecule in the body of mammals including humans and is an extremely important intermediate in the chemical industry.

    Products: Neophyr 225 ppm mol/mol Gas zur medizinischen Anwendung, druckverdichtet, Neophyr 450 ppm mol/mol Gas zur medizinischen Anwendung, druckverdichtet
  5. Drug

    Leukotriene D4

    go.drugbank.com/drugs/DB11858
    Investigational

    Leukotriene D4 has been used in trials studying the diagnostic of Asthma and Allergic Rhinitis.

  6. Drug

    Nivocasan

    go.drugbank.com/drugs/DB12720
    Investigational

    Nivocasan has been used in trials studying the treatment of HCV Infection and Nonalcoholic Steatohepatitis.

  7. Drug

    Z-160

    go.drugbank.com/drugs/DB12743
    Investigational

    Z160 has been used in trials studying the treatment of Postherpetic Neuralgia and Lumbosacral Radiculopathy.

  8. Drug

    Atreleuton

    go.drugbank.com/drugs/DB12758
    Investigational

    Atreleuton has been used in trials studying the treatment of Atherosclerosis and Coronary Artery Disease.

  9. Drug

    Ecromeximab

    go.drugbank.com/drugs/DB12797
    Investigational

    Ecromeximab has been used in trials studying the treatment of Cutaneous Melanoma and Metastatic Melanoma.

  10. Drug

    Cebranopadol

    go.drugbank.com/drugs/DB12830
    Investigational

    Cebranopadol has been used in trials studying the treatment of Pain, Neoplasms, and Chronic Pain.